Immunotherapy for renal carcinoma: theoretical basis and current standard of care.
Vasey
P A
PA
CRC Department of Medical Oncology, University of Glasgow, Garscube Estate, Switchback Road, Bearsden, Glasgow G61 1BD.
D002292:Carcinoma, Renal Cell / Q000188:drug therapy / Q000276:immunology / Q000628:therapy*; D004359:Drug Therapy, Combination; D006801:Humans; D007167:Immunotherapy / Q000379:methods / Q000592:standards*; D016898:Interferon-alpha / Q000276:immunology / Q000627:therapeutic use; D007376:Interleukin-2 / Q000276:immunology / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000188:drug therapy / Q000276:immunology / Q000628:therapy*
D016898:Interferon-alpha; D007376:Interleukin-2